Vanderbilt Ingram Cancer Center

Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth. Read More

Ordinary cells can be transformed into cancer cells through epigenetics — changes to DNA that turn genes on or off. Those gene changes can protect cells or make them vulnerable to disease processes including cancer. Read More

Vanderbilt-Ingram Cancer Center (VICC) may nominate two junior faculty candidates for the Gabrielle’s Angel Foundation for Cancer Research Awards: one in Mainstream/Conventional research, and one in Integrative Medicine research for 2017. Read More

The Vanderbilt-Ingram Cancer Center (VICC) has been invited to participate in The V Foundation 2017 Pediatric Cancer Research–Immunology or Immunotherapy Award. Read More

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt, has been elected to The American Society for Clinical Investigation (ASCI). Read More

Richard Abramson, M.D., will engage in creative program development as the Department of Radiology’s first Vice Chair for Innovation. Read More

Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center Annual Scientific Retreat, to be held Thursday, May 4. Read More

  Christine Lovly, Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected to The American Society for Clinical Investigation (ASCI). The ASCI is an elite honor society of physician-scientists. The Society, founded in 1908,… Read More

Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat May 4. Read More

W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation. Read More

A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy. Read More

Nashville musician and producer Jesse Boyce compares the anxiety he felt just before receiving palliative radiation therapy to the jitters he often experienced before going on stage. The instant treatment began — and as the first note rang out — his anxiety was replaced by a sense of peace and determination. Read More

Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen. Read More

John Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology. Read More

Applications are being sought for funding by the American Cancer Society‐Institutional Research Grant program. These funds are designed to provide seed money to support junior faculty members with an interest in cancer research who do not have external grant support. Read More

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has been selected to lead a clinical research trial of combination therapy using two targeted drugs for the treatment of a specific form of lung cancer. Read More

DS Services of America Inc. recently presented a $100,000 gift to Vanderbilt-Ingram Cancer Center (VICC) to support breast cancer research. Read More

A novel fluorescent nanobeacon can distinguish normal from diseased colon tissue, potentially offering advantages for colorectal cancer screening. Read More

A hoarse voice or persistent sore throat that lasts for weeks may seem like a mild nuisance, but those same symptoms could be early signs of head and neck cancer. To help patients determine their risk for disease and detect problems at an early stage, the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 7, from 9 a.m. to 3 p.m. Read More

The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8. Read More